IL6 and COVID-19: Our findings are consistent with prior literature demonstrating elevations in inflammatory cytokines and chemokines such as IL-6, IL-8, IL-10, IP-10, TNFR-1 and TREM-1 in the development of severe compared to mild COVID-19 (6, 8–10, 29–31).